Argaw Kidane
27Patents
5h-index
9Co-inventors
62Inventor score
Filing activity: May 11, 2001 → Apr 23, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7611728B2 | Osmotic delivery of therapeutic compounds by solubility enhancement | Human Necessities | 69 | Expired |
| US8747897B2 | Osmotic drug delivery system | Human Necessities | 44 | Active |
| US8617600B2 | Modified release preparations containing oxcarbazepine and derivatives thereof | Human Necessities | 26 | Active |
| US7410978B2 | Once daily dosage forms of trospium | Human Necessities | 11 | Expired |
| US7763635B2 | Once daily dosage forms of trospium | Human Necessities | 10 | Active |
| US9119792B2 | Modified release preparations containing oxcarbazepine and derivatives thereof | Human Necessities | 5 | Active |
| US6656470B2 | Vaccine composition, method of preparing the same, and method of vaccinating vertebrates | Human Necessities | 5 | Expired |
| US7722898B2 | Modified-release preparations containing oxcarbazepine and derivatives thereof | Human Necessities | 4 | Active |
| US7910131B2 | Method of treating seizures using modified release formulations of oxcarbazepine | Human Necessities | 3 | Active |
| US9393203B2 | Osmotic drug delivery system | Human Necessities | 2 | Active |
| US9119791B2 | Modified release preparations containing oxcarbazepine and derivatives thereof | Human Necessities | 2 | Active |
| US8821930B2 | Modified release preparations containing oxcarbazepine and derivatives thereof | Human Necessities | 1 | Active |
| US10220042B2 | Modified release preparations containing oxcarbazepine and derivatives thereof | Human Necessities | 1 | Active |
| US9351975B2 | Modified release preparations containing oxcarbazepine and derivatives thereof | Human Necessities | 1 | Active |
| US9855278B2 | Modified release preparations containing oxcarbazepine and derivatives thereof | Human Necessities | 1 | Active |
| US9370525B2 | Modified release preparations containing oxcarbazepine and derivatives thereof | Human Necessities | 1 | Active |
| US8709476B2 | Compositions of quaternary ammonium compounds containing bioavailability enhancers | Human Necessities | 0 | Active |
| US8017149B2 | Modified release preparations containing oxcarbazepine and derivatives thereof | Human Necessities | 0 | Active |
| US10154965B2 | Osmotic drug delivery system | Human Necessities | 0 | Active |
| US8211464B2 | Modified release preparations containing oxcarbazepine and derivatives thereof | Human Necessities | 0 | Active |
| US7759359B2 | Method of treating bladder dysfunction with once-a-day trospium salt formulation | Human Necessities | 0 | Active |
| US7781449B2 | Trospium chloride treatment method | Human Necessities | 0 | Active |
| US11166960B2 | Modified release preparations containing oxcarbazepine and derivatives thereof | Human Necessities | 0 | Active |
| US7781448B2 | Once daily dosage forms of trospium | Human Necessities | 0 | Active |
| US11896599B2 | Modified release preparations containing oxcarbazepine and derivatives thereof | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.